Analystreport

CTI BioPharma Corp. (NASDAQ: CTIC) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.

CTI BioPharma Corp.  (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com